Latest period
$1.56B
YoY change
+0.6%
5Y CAGR
+20.5%
Peak year (2025)
$1.61B
Latest annual
$1.61B
Total Equity history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: $1.61B
Total Equity growth chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: +0.6%
Total Equity history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| 2025 | $1.61B | +0.6% | +$10.07M | ||
| 2024 | $1.60B | +7.5% | +$110.78M | ||
| 2023 | $1.48B | +143.9% | +$875.79M | ||
| 2022 | $608.74M | -11.8% | −$81.25M | ||
| 2021 | $689.99M | +9.2% | +$57.90M | ||
| 2020 | $632.09M | +256.2% | +$454.62M | ||
| 2019 | $177.47M | -1965.6% | +$186.99M | ||
| 2018 | −$9.51M | -82.4% | +$44.59M | ||
| 2017 | −$54.11M | -50.1% | +$54.25M | ||
| 2016 | −$108.35M | +28.8% | −$24.23M | ||
| 2015 | −$84.13M | -171.6% | −$201.64M | ||
| 2014 | $117.52M | -77.3% | −$400.67M | ||
| 2013 | $518.19M | -18.6% | −$118.04M | ||
| 2012 | $636.22M | +17.9% | +$96.64M | ||
| 2011 | $539.58M | -6.0% | −$34.66M | ||
| 2010 | $574.24M | +11.6% | +$59.67M | ||
| 2009 | $514.57M | +17.4% | +$76.38M | ||
| 2008 | $438.19M | -0.0% | −$129.00K | ||
| 2007 | $438.32M | +6.9% | +$28.46M | ||
| 2006 | $409.86M | +11.1% | +$40.85M | ||
| 2005 | $369.01M | -7.2% | −$28.65M | ||
| 2004 | $397.66M | -3.8% | −$15.63M | ||
| 2003 | $413.29M | +21.2% | +$72.32M | ||
| 2002 | $340.97M | +13.0% | +$39.24M | ||
| 2001 | $301.73M | +15.3% | +$39.98M | ||
| 2000 | $261.75M | -7.9% | −$22.55M | ||
| 1999 | $284.30M | -7.6% | −$23.50M | ||
| 1998 | $307.80M | +1.7% | +$5.10M | ||
| 1997 | $302.70M | -6.2% | −$20.00M | ||
| 1996 | $322.70M | +15.6% | +$43.60M | ||
| 1995 | $279.10M | +179.7% | +$179.30M | ||
| 1994 | $99.80M | +19.4% | +$16.20M | ||
| 1993 | $83.60M | +18.8% | +$13.20M | ||
| 1992 | $70.40M | +123.5% | +$38.90M | ||
| 1991 | $31.50M | — | — |
- 2025$1.61B+0.6%
- 2024$1.60B+7.5%
- 2023$1.48B+143.9%
- 2022$608.74M-11.8%
- 2021$689.99M+9.2%
- 2020$632.09M+256.2%
- 2019$177.47M-1965.6%
- 2018−$9.51M-82.4%
- 2017−$54.11M-50.1%
- 2016−$108.35M+28.8%
- 2015−$84.13M-171.6%
- 2014$117.52M-77.3%
- 2013$518.19M-18.6%
- 2012$636.22M+17.9%
- 2011$539.58M-6.0%
- 2010$574.24M+11.6%
- 2009$514.57M+17.4%
- 2008$438.19M-0.0%
- 2007$438.32M+6.9%
- 2006$409.86M+11.1%
- 2005$369.01M-7.2%
- 2004$397.66M-3.8%
- 2003$413.29M+21.2%
- 2002$340.97M+13.0%
- 2001$301.73M+15.3%
- 2000$261.75M-7.9%
- 1999$284.30M-7.6%
- 1998$307.80M+1.7%
- 1997$302.70M-6.2%
- 1996$322.70M+15.6%
- 1995$279.10M+179.7%
- 1994$99.80M+19.4%
- 1993$83.60M+18.8%
- 1992$70.40M+123.5%
- 1991$31.50M—
Total Equity values are taken from IDEXX Laboratories's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's latest reported total equity is $1.56B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, IDEXX Laboratories (IDXX) total equity totalled $1.61B – edged up 0.6% year-over-year.
IDEXX Laboratories total equity has grown for 3 consecutive years, with a +20.5% compound annual growth rate over 2020–2025 (5 years).
The highest annual total equity of $1.61B was reported in 2025. The lowest in the available history was −$108.35M in 2016.
IDEXX Laboratories Total Equity by Year
IDEXX Laboratories Total Equity 2025: $1.61B
IDEXX Laboratories posted total equity of $1.61B in 2025, edged up 0.6% from 2024. This figure represents the highest annual value in the available history.
IDEXX Laboratories Total Equity 2024: $1.60B
In 2024, IDEXX Laboratories reported total equity of $1.60B, grew 7.5% from 2023.
IDEXX Laboratories Total Equity 2023: $1.48B
IDEXX Laboratories total equity in 2023 was $1.48B, surged 143.9% from 2022.
IDEXX Laboratories Total Equity 2022: $608.74M
2022's total equity for IDEXX Laboratories came in at $608.74M, declined 11.8% below 2021.
IDEXX Laboratories Total Equity 2021: $689.99M
IDEXX Laboratories total equity in 2021 was $689.99M.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers by Total Equity
Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation